During the past decade, Universitäres Herzzentrum Hamburg conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 2 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitäres Herzzentrum Hamburg" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "JenaValve Technology, Inc." with 3 trials sponsored, "Biotronik SE & Co. KG" with 2 trials sponsored, "Charite University, Berlin, Germany" with 2 trials sponsored and "Dr. F. Köhler Chemie GmbH" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitäres Herzzentrum Hamburg" #1 collaborator was "Universitätsklinikum Hamburg-Eppendorf" with 3 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Axxos GmbH" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Universitäres Herzzentrum Hamburg" are "Coronary Artery Disease" (8 trials), "Heart Failure" (4 trials), "Aortic Valve Stenosis" (3 trials), "Atrial Fibrillation" (3 trials) and "Ventricular Tachycardia" (3 trials). Many other conditions were trialed in "Universitäres Herzzentrum Hamburg" in a lesser frequency.

Most popular intervention types in "Universitäres Herzzentrum Hamburg" are "Device" (23 trials), "Drug" (8 trials), "Procedure" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Custodiol" (2 trials), "Custodiol-N" (2 trials), "JenaValve Pericardial TAVR System" (2 trials) and "VT ablation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Universitäres Herzzentrum Hamburg" are 42 trials for "All" genders.

Currently, there are NaN active trials in "Universitäres Herzzentrum Hamburg". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Universitäres Herzzentrum Hamburg, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Universitäres Herzzentrum Hamburg, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 18 trials that are defined as “Not Applicable".